Carisma Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Carisma Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2015 to Q2 2024.
  • Carisma Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 41.5M shares, a 3.19% increase year-over-year.
  • Carisma Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 33.5M shares, a 1475% increase from 2022.
  • Carisma Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.13M shares, a 98.8% decline from 2021.
  • Carisma Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 182M shares, a 54.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 41.5M +1.29M +3.19% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 40.9M +28.2M +220% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 33.5M +31.4M +1475% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 40.3M +38.1M +1740% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 40.3M +38.2M +1853% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 12.8M +10.7M +521% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 2.13M -180M -98.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 2.19M -195M -98.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 2.06M -173M -98.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 2.06M -155M -98.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 182M +64.1M +54.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 197M +78.9M +66.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 175M +62.8M +55.8% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-08-25
Q1 2021 157M +47.2M +43% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 118M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 118M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 113M +31.8M +39.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 110M +32.4M +41.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q2 2019 80.7M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 77.5M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2017 24.7M +4.2M +20.5% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-17
Q3 2016 20.5M +1.15M +5.95% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-17
Q3 2015 19.3M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.